Co-Diagnostics prices USD 3 million at-the-market private placement under Nasdaq rules

Co-Diagnostics, Inc.

Co-Diagnostics, Inc.

CODX

0.00
  • Co-Diagnostics priced a $3 million private placement at $1.82 per share, selling 1,647,447 shares of common stock or pre-funded warrants.
  • Institutional investors also received warrants to buy up to 3,294,894 shares at $1.57, exercisable immediately, expiring in five years.
  • Closing is expected around May 21, subject to customary conditions.
  • The securities were sold in an unregistered offering under Section 4(a)(2) or Regulation D, with a resale registration statement to be filed.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Co-Diagnostics Inc. published the original content used to generate this news brief on May 19, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.